Clinical Research Directory
Browse clinical research sites, groups, and studies.
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
Sponsor: Peking University First Hospital
Summary
Pancreatic cancer remains a devastating disease with an average 5-year survival rate of about 3-5%. Previous retrospective studies showed that perioperative epidural block and/or dexamethasone are associated with improved outcome after cancer surgery. This randomized trial aims to investigate the effect of perioperative epidural block and/or dexamethasone on long-term survival in patients following pancreatic cancer surgery.
Official title: Effect of Perioperative Epidural Block and Dexamethasone on Outcome of Patients Undergoing Pancreatic Cancer Surgery: a 2×2 Factorial Randomized Controlled Trial
Key Details
Gender
All
Age Range
45 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
260
Start Date
2019-09-11
Completion Date
2026-11
Last Updated
2025-07-31
Healthy Volunteers
No
Interventions
Epidural block
Epidural block (with 0.375% ropivacaine) is performed during surgery. Patient-controlled epidural analgesia (with a mixture of 0.12% ropivacaine and 0.5 microgram/ml sufentanyl) is provided after surgery.
Dexamethasone
Dexamethasone (10 mg) is administered intravenously before anesthesia induction.
Locations (1)
Peking University First Hospital
Beijing, Beijing Municipality, China